Clinical Trials

Human Placental-Derived Stem Cell Transplantation

Early Check: Expanded Screening in Newborns

Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies

Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases

A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders